Max Wintermark

Title: Max Wintermark: Innovator in Stroke Treatment Technology

Introduction

Max Wintermark is a prominent inventor based in Lausanne, Switzerland. He has made significant contributions to the field of medical technology, particularly in the evaluation and treatment of stroke patients. With a total of two patents to his name, Wintermark's work is at the forefront of improving patient outcomes in acute stroke care.

Latest Patents

Wintermark's latest patents focus on a method and apparatus for determining treatment for stroke. This innovative approach evaluates acute stroke patients to ascertain whether they will benefit from thrombolysis therapy. The method involves obtaining measurements of cerebral blood flow and cerebral blood volume in the brain of a stroke patient. It identifies ischemic areas where cerebral blood flow is below a certain threshold and creates a penumbra-infarct map. This map helps in determining the infarct area, which corresponds to regions with low cerebral blood volume, and the penumbra area, where blood volume is higher. By calculating the ratio of penumbra size to the total of penumbra and infarct size, the method identifies candidates for thrombolysis therapy based on predetermined values.

Career Highlights

Max Wintermark is affiliated with the Université de Lausanne, where he continues to advance research in stroke treatment technologies. His work has garnered attention for its potential to revolutionize how acute strokes are assessed and treated, ultimately improving patient care.

Collaborations

Wintermark collaborates with esteemed colleagues such as Jean-Philippe Thiran and Refo Antoine Meuli. Their combined expertise contributes to the innovative research and development of medical technologies aimed at enhancing stroke treatment.

Conclusion

Max Wintermark's contributions to stroke treatment technology exemplify the impact of innovation in healthcare. His patents and ongoing research are paving the way for improved diagnostic and therapeutic strategies for stroke patients.